rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - Æxlishemjandi lyf - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
fluconazol krka hart hylki 150 mg
krka sverige ab - fluconazolum inn - hart hylki - 150 mg
bisoprolol medical valley filmuhúðuð tafla 5 mg
medical valley invest ab - bisoprololum fúmarat - filmuhúðuð tafla - 5 mg
carvedilol stada tafla 3,125 mg
stada arzneimittel ag - carvedilolum inn - tafla - 3,125 mg
carvedilol stada tafla 6,25 mg
stada arzneimittel ag - carvedilolum inn - tafla - 6,25 mg
diflucan mixtúruduft, lausn 10 mg/ml
pfizer aps - fluconazolum inn - mixtúruduft, lausn - 10 mg/ml
diltiazem hcl alvogen (dilmin) forðatafla 120 mg
alvogen ehf. - diltiazemum hýdróklóríð - forðatafla - 120 mg
bisoprolol medical valley filmuhúðuð tafla 10 mg
medical valley invest ab - bisoprololum fúmarat - filmuhúðuð tafla - 10 mg
candizol hart hylki 150 mg
actavis group ptc ehf. - fluconazolum inn - hart hylki - 150 mg